and for targeted
therapy of age-associated pathologies, including malignant neoplasms. In this regard, the study
FEDOROVA, Y.Y.,
KARUNAS, A.S.,
GIMALOVA, G.F.,
KHUSNUTDINOVA, E.K.,
SAVELIEVA, O.N,
MURZINA, R.R.,
GATIYATULLIN, R.F.,
ETKINA, E.I. (2019) –60% of differences in sensitivity to
therapy in patients with BA is due to genetic variability. We studied
YUE, E.,
TUGUZBAEVA, G.M.,
CHEN, X.,
LI, A.,
SUN, X.,
DONG, C.,
LIU, Y.,
YU, Y.,
ZAHRA, S.M.,
JIANG, Y.,
BAI, Y.,
QIN, Y.,
SHAN, Q.,
DU, Z. (2019) of anthocyanin on oral squamous cell carcinoma and identify effective targets for
therapy. Methods: Cellviability